Effects of Maitake (Grifola frondosa) glucan in HIV-infected patients
- 145 Downloads
The effects of MD-Fraction, a β-glucan extracted from Maitake mushroom (Grifola frondosa), on the health status of individuals suffering from HIV infection were evaluated in a long-term trial. The HIV status of the 35 respondents who participated in the study was followed by monitoring CD4+ cell counts, viral load measure, symptoms of HIV infection, status of secondary disease, and sense of well-being. Twenty patients reported an increase in CD4+ cell counts to 1.4–1.8 times, and 8 patients reported a decrease to 0.8–0.5 times. Viral load was reported to increase in 9 patients and decrease in 10 patients. However, 85% of respondents reported an increased sense of well-being with regard to various symptoms and secondary diseases caused by HIV. These results suggest that Maitake D-Fraction had a positive impact in HIV patients.
Key Wordsanti-HIV activity CD4+ cell Grifola frondosa (Maitake) IL-2 MD-Fraction
Unable to display preview. Download preview PDF.
- Nanba H. and George S. R. 1993. Effects of Maitake (Grifola frondosa) for HIV-positive or fibroid tumor patients. 113th Congr. Pharmaceutical Society of Japan, Osaka, Japan, March 29–31, p. 212.Google Scholar
- Nanba H. 1993. Anti-tumor activity of orally administered D-Fraction from Maitake mushroomGrifola frondosa. J. Naturopath. Med.4: 10–15.Google Scholar